Greten TF - Search Results

1

Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database.

Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF. Eggert T, et al. Among authors: greten tf. United European Gastroenterol J. 2013 Oct;1(5):351-7. doi: 10.1177/2050640613501507. United European Gastroenterol J. 2013. PMID: 24917983 Free PMC article.

2

Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes.

Greten TF, Korangy F, Neumann G, Wedemeyer H, Schlote K, Heller A, Scheffer S, Pardoll DM, Garbe AI, Schneck JP, Manns MP. Greten TF, et al. J Immunol Methods. 2002 Dec 20;271(1-2):125-35. doi: 10.1016/s0022-1759(02)00346-0. J Immunol Methods. 2002. PMID: 12445736

3

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.

Scheffer SR, Nave H, Korangy F, Schlote K, Pabst R, Jaffee EM, Manns MP, Greten TF. Scheffer SR, et al. Among authors: greten tf. Int J Cancer. 2003 Jan 10;103(2):205-11. doi: 10.1002/ijc.10777. Int J Cancer. 2003. PMID: 12455034 Free article.

4

CD40 in hepatocellular carcinoma: relevant or not?

Greten TF, Ott M. Greten TF, et al. Eur J Gastroenterol Hepatol. 2003 Feb;15(2):113-4. doi: 10.1097/00042737-200302000-00001. Eur J Gastroenterol Hepatol. 2003. PMID: 12560752

5

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.

Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF. Korangy F, et al. Among authors: greten tf. Clin Cancer Res. 2004 Jul 1;10(13):4332-41. doi: 10.1158/1078-0432.CCR-04-0181. Clin Cancer Res. 2004. PMID: 15240519

6

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.

Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Ormandy LA, et al. Among authors: greten tf. Cancer Res. 2005 Mar 15;65(6):2457-64. doi: 10.1158/0008-5472.CAN-04-3232. Cancer Res. 2005. PMID: 15781662

7

Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.

Garbe AI, Vermeer B, Gamrekelashvili J, von Wasielewski R, Greten FR, Westendorf AM, Buer J, Schmid RM, Manns MP, Korangy F, Greten TF. Garbe AI, et al. Among authors: greten tf, greten fr. Cancer Res. 2006 Jan 1;66(1):508-16. doi: 10.1158/0008-5472.CAN-05-2383. Cancer Res. 2006. PMID: 16397267

8

Immunotherapy of hepatocellular carcinoma.

Greten TF, Manns MP, Korangy F. Greten TF, et al. J Hepatol. 2006 Dec;45(6):868-78. doi: 10.1016/j.jhep.2006.09.004. Epub 2006 Sep 29. J Hepatol. 2006. PMID: 17046096 Review. No abstract available.

9

Necrotic tumor cell death in vivo impairs tumor-specific immune responses.

Gamrekelashvili J, Krüger C, von Wasielewski R, Hoffmann M, Huster KM, Busch DH, Manns MP, Korangy F, Greten TF. Gamrekelashvili J, et al. Among authors: greten tf. J Immunol. 2007 Feb 1;178(3):1573-80. doi: 10.4049/jimmunol.178.3.1573. J Immunol. 2007. PMID: 17237406

10

Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.

Obermann S, Petrykowska S, Manns MP, Korangy F, Greten TF. Obermann S, et al. Among authors: greten tf. Immunology. 2007 Sep;122(1):90-7. doi: 10.1111/j.1365-2567.2007.02616.x. Epub 2007 Apr 30. Immunology. 2007. PMID: 17472719 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

259 results

Search Page